• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测中国东部地区2型糖尿病发病风险的新评分系统:上海宝钢队列研究,纳入非酒精性脂肪性肝病因素

New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort.

作者信息

Chen Guang-Yu, Cao Hai-Xia, Li Feng, Cai Xiao-Bo, Ao Qing-Hong, Gao Yan, Fan Jian-Gao

机构信息

Center for Fatty Liver Disease Department of Gastroenterology Xinhua Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

Department of Gastroenterology Zhongshan Hospital Fudan University Shanghai China.

出版信息

J Diabetes Investig. 2016 Mar;7(2):206-11. doi: 10.1111/jdi.12395. Epub 2015 Aug 13.

DOI:10.1111/jdi.12395
PMID:27042272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4773660/
Abstract

AIMS/INTRODUCTION: The present study aimed to explore the incidence of type 2 diabetes, and to develop a risk-scoring model for predicting diabetes among the adult health check-up population in East China.

MATERIALS AND METHODS

Participants from the Shanghai Baosteel Cohort (age ≥20 years) without diabetes at baseline were recruited in a 6-year follow-up study. In order to explore risk factors for diabetes, this cohort was categorized into two groups: new diabetes and no diabetes. Three models were developed by Cox regression analysis. The model accuracy was assessed using the area under the receiver operating characteristic curve.

RESULTS

A total of 6,542 individuals were included in the Shanghai Baosteel Cohort Study. Of them, 368 (5.6%) developed type 2 diabetes at the end of the follow-up period. Cox regression analysis found a close association between incident type 2 diabetes and several risk factors including non-alcoholic fatty liver diseases at baseline. The Shanghai Baosteel Score including advanced age (2 points), hypertriglyceridemia (2 points), obesity (2 points), non-alcoholic fatty liver diseases (2 points) and impaired fasting glucose (3 points) had a good diagnostic performance with estimated area under the receiver operating characteristic curve (0.724), sensitivity (57.9%) and specificity (72.2%) at a cut-off point of >3.

CONCLUSIONS

A risk-scoring system including non-alcoholic fatty liver diseases can help identify individuals at a high risk of diabetes in the East Chinese population.

摘要

目的/引言:本研究旨在探讨2型糖尿病的发病率,并建立一个风险评分模型,用于预测中国东部地区成年健康体检人群中的糖尿病发病情况。

材料与方法

在一项为期6年的随访研究中,招募了来自上海宝钢队列(年龄≥20岁)且基线时无糖尿病的参与者。为了探究糖尿病的危险因素,该队列被分为两组:新发糖尿病组和无糖尿病组。通过Cox回归分析建立了三个模型。使用受试者工作特征曲线下面积评估模型准确性。

结果

上海宝钢队列研究共纳入6542人。其中,368人(5.6%)在随访期末发生了2型糖尿病。Cox回归分析发现,新发2型糖尿病与包括基线时非酒精性脂肪性肝病在内的多个危险因素密切相关。上海宝钢评分包括高龄(2分)、高甘油三酯血症(2分)、肥胖(2分)、非酒精性脂肪性肝病(2分)和空腹血糖受损(3分),在截断点>3时,受试者工作特征曲线下面积估计值为0.724,敏感性为57.9%,特异性为72.2%,具有良好的诊断性能。

结论

一个包括非酒精性脂肪性肝病的风险评分系统有助于识别中国东部人群中糖尿病高危个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/450c/4773660/d34754d1ea51/JDI-7-206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/450c/4773660/d34754d1ea51/JDI-7-206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/450c/4773660/d34754d1ea51/JDI-7-206-g001.jpg

相似文献

1
New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort.用于预测中国东部地区2型糖尿病发病风险的新评分系统:上海宝钢队列研究,纳入非酒精性脂肪性肝病因素
J Diabetes Investig. 2016 Mar;7(2):206-11. doi: 10.1111/jdi.12395. Epub 2015 Aug 13.
2
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
3
The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.非酒精性脂肪性肝病对非超重个体发生2型糖尿病的影响。
Liver Int. 2016 Feb;36(2):275-83. doi: 10.1111/liv.12912. Epub 2015 Jul 30.
4
Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).用于预测代谢综合征患者非酒精性脂肪性肝病(NAFLD-MS 评分)的临床风险评分。
Liver Int. 2017 Oct;37(10):1535-1543. doi: 10.1111/liv.13413. Epub 2017 Apr 6.
5
Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.中国人群中非酒精性脂肪性肝病与2型糖尿病的双向关联:来自东风-同济队列研究的证据。
PLoS One. 2017 Mar 28;12(3):e0174291. doi: 10.1371/journal.pone.0174291. eCollection 2017.
6
Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.基于基线时的简单心代谢危险因素预测新发脂肪肝。
BMC Gastroenterol. 2012 Jul 6;12:84. doi: 10.1186/1471-230X-12-84.
7
Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.乙型肝炎病毒感染与非酒精性脂肪性肝病风险:一项基于人群的队列研究。
Liver Int. 2019 Jan;39(1):70-80. doi: 10.1111/liv.13933. Epub 2018 Aug 19.
8
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。
Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.
9
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者中无创性纤维化模型预测轻度至中度纤维化的性能。
Liver Int. 2016 Apr;36(4):572-9. doi: 10.1111/liv.13054. Epub 2016 Jan 24.
10
A risk-score model for predicting risk of type 2 diabetes mellitus in a rural Chinese adult population: A cohort study with a 6-year follow-up.中国农村成年人 2 型糖尿病风险评分模型:一项 6 年随访的队列研究。
Diabetes Metab Res Rev. 2017 Oct;33(7). doi: 10.1002/dmrr.2911. Epub 2017 Jul 13.

引用本文的文献

1
Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models.使用异速生长比例法和基于生理的药代动力学模型对用于非酒精性脂肪性肝炎治疗的小分子XZP-5610进行剂量预测和药代动力学模拟。
Pharmaceuticals (Basel). 2024 Mar 13;17(3):369. doi: 10.3390/ph17030369.
2
Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.2型糖尿病和非酒精性脂肪性肝病患者循环骨形态发生蛋白-9水平降低。
Int J Gen Med. 2022 Dec 7;15:8539-8546. doi: 10.2147/IJGM.S385513. eCollection 2022.
3

本文引用的文献

1
The impact of health systems on diabetes care in low and lower middle income countries.卫生系统对低收入和中低收入国家糖尿病护理的影响。
Curr Diab Rep. 2015 Apr;15(4):20. doi: 10.1007/s11892-015-0591-8.
2
A systematic review of the direct economic burden of type 2 diabetes in china.中国 2 型糖尿病直接经济负担的系统评价。
Diabetes Ther. 2015 Mar;6(1):7-16. doi: 10.1007/s13300-015-0096-0. Epub 2015 Feb 5.
3
Global estimates of diabetes prevalence for 2013 and projections for 2035.全球 2013 年糖尿病患病率估计值及 2035 年预测值。
Risk Factors and Prediction Models for Nonalcoholic Fatty Liver Disease Based on Random Forest.
基于随机森林的非酒精性脂肪性肝病的危险因素和预测模型。
Comput Math Methods Med. 2022 Aug 9;2022:8793659. doi: 10.1155/2022/8793659. eCollection 2022.
4
Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population.超声和定量 MRI 诊断的肝脏脂肪变与普通人群中糖尿病前期的关系。
Sci Rep. 2021 Jun 24;11(1):13276. doi: 10.1038/s41598-021-92681-3.
5
Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.非酒精性脂肪性肝病与日本新发糖尿病的关系:一项使用倾向评分匹配的回顾性队列研究。
Lipids Health Dis. 2021 Jun 15;20(1):59. doi: 10.1186/s12944-021-01485-x.
6
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.非酒精性脂肪性肝病与 2 型糖尿病:双向关系。
Can J Gastroenterol Hepatol. 2020 Dec 28;2020:6638306. doi: 10.1155/2020/6638306. eCollection 2020.
7
Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum.人类与分子遗传学为脂肪肝疾病和糖尿病难题带来启示。
Endocrinol Diabetes Metab. 2020 Sep 4;3(4):e00179. doi: 10.1002/edm2.179. eCollection 2020 Oct.
8
Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.维生素D补充剂对非酒精性脂肪性肝病患儿的疗效:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Jul 31;99(31):e20960. doi: 10.1097/MD.0000000000020960.
9
Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.代谢综合征和空腹血糖受损对中年日本人群 2 型糖尿病发病率的风险和人群归因分数:爱知工作者队列研究。
J Diabetes Investig. 2020 Sep;11(5):1163-1169. doi: 10.1111/jdi.13230. Epub 2020 Mar 3.
10
Comprehensive Evaluation System of Occupational Hazard Prevention and Control in Iron and Steel Enterprises Based on A Modified Delphi Technique.基于改进 Delphi 技术的钢铁企业职业病危害防控综合评价体系。
Int J Environ Res Public Health. 2020 Jan 20;17(2):667. doi: 10.3390/ijerph17020667.
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49. doi: 10.1016/j.diabres.2013.11.002. Epub 2013 Dec 1.
4
Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.在非洲,预防、治疗和控制心血管疾病和糖尿病的干预措施的成本、效益和效果。
Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):314-21. doi: 10.1016/j.pcad.2013.09.001.
5
Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology.非酒精性脂肪性肝病及其相关代谢紊乱的诊断和治疗:中国内分泌学会肝脏与代谢学组的共识声明。
J Diabetes. 2013 Dec;5(4):406-15. doi: 10.1111/1753-0407.12056. Epub 2013 Jun 4.
6
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.非酒精性脂肪性肝病的临床可用性作为韩国男性 2 型糖尿病的早期预测指标:一项 5 年前瞻性队列研究。
Hepatology. 2013 Apr;57(4):1378-83. doi: 10.1002/hep.26183.
7
Risk models and scores for type 2 diabetes: systematic review.2 型糖尿病风险模型和评分:系统评价。
BMJ. 2011 Nov 28;343:d7163. doi: 10.1136/bmj.d7163.
8
Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study.非酒精性脂肪肝和空腹血糖受损对 2 型糖尿病发生的联合影响:一项 4 年回顾性纵向研究。
Diabetes Care. 2011 Mar;34(3):727-9. doi: 10.2337/dc10-1991. Epub 2011 Jan 28.
9
A simple Chinese risk score for undiagnosed diabetes.一个用于诊断未确诊糖尿病的简单中文风险评分。
Diabet Med. 2010 Mar;27(3):274-81. doi: 10.1111/j.1464-5491.2010.02943.x.
10
A simple tool detected diabetes and prediabetes in rural Chinese.一种简单的工具可在农村中国人群中检测糖尿病和糖尿病前期。
J Clin Epidemiol. 2010 Sep;63(9):1030-5. doi: 10.1016/j.jclinepi.2009.11.012. Epub 2010 Mar 1.